| Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:sgen | https://www.glassdoor.com?employer_id=12902 | 12902 | May 4th, 2024 12:00AM | Open | Seagen | Open | Company - Public | Biotech & Pharmaceuticals | Bothell, WA | 1998 | 4.20 | 82% | 64% | 87% | 4.40 | 4.40 | 4.00 | 4.30 | 3.90 | 3.90 | 11.00 | 6.00 | 29.00 | 42.00 | 78.00 | 166.00 | 192.00 | 50.00 | 6.627% | 3.614% | 17.47% | 25.301% | 46.988% | 15.00 | 428.00 | 0.54 | 0.21 | 0.25 | 0.66 | 0.18 | 0.11 | 0.01 | 0.01 | 0.02 | David Epstein | May 4th, 2024 06:33PM | May 4th, 2024 06:33PM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | |||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=7312 | 7312 | May 4th, 2024 12:00AM | Open | Oncothyreon | Open | Company - Public | Biotech & Pharmaceuticals | Seattle, WA | 4.40 | 100% | 100% | 100% | 4.60 | 4.20 | 4.20 | -1.00 | 4.20 | 3.80 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 4.00 | 1.00 | 1.00 | Robert L. Kirkman | May 4th, 2024 06:33PM | May 4th, 2024 06:33PM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||||||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=12902 | 12902 | May 3rd, 2024 12:00AM | Open | Seagen | Open | Company - Public | Biotech & Pharmaceuticals | Bothell, WA | 1998 | 4.20 | 82% | 64% | 87% | 4.40 | 4.40 | 4.00 | 4.30 | 3.90 | 3.90 | 11.00 | 6.00 | 29.00 | 42.00 | 78.00 | 166.00 | 192.00 | 50.00 | 6.627% | 3.614% | 17.47% | 25.301% | 46.988% | 15.00 | 428.00 | 0.54 | 0.21 | 0.25 | 0.66 | 0.18 | 0.11 | 0.01 | 0.01 | 0.02 | David Epstein | May 3rd, 2024 02:55PM | May 3rd, 2024 02:55PM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | |||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=7312 | 7312 | May 3rd, 2024 12:00AM | Open | Oncothyreon | Open | Company - Public | Biotech & Pharmaceuticals | Seattle, WA | 4.40 | 100% | 100% | 100% | 4.60 | 4.20 | 4.20 | -1.00 | 4.20 | 3.80 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 4.00 | 1.00 | 1.00 | Robert L. Kirkman | May 3rd, 2024 02:55PM | May 3rd, 2024 02:55PM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||||||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=12902 | 12902 | May 2nd, 2024 12:00AM | Open | Seagen | Open | Company - Public | Biotech & Pharmaceuticals | Bothell, WA | 1998 | 4.20 | 82% | 64% | 87% | 4.40 | 4.40 | 4.00 | 4.30 | 3.90 | 3.90 | 11.00 | 6.00 | 29.00 | 42.00 | 78.00 | 166.00 | 192.00 | 50.00 | 6.627% | 3.614% | 17.47% | 25.301% | 46.988% | 15.00 | 428.00 | 0.54 | 0.21 | 0.25 | 0.66 | 0.18 | 0.11 | 0.01 | 0.01 | 0.02 | David Epstein | May 2nd, 2024 09:46AM | May 2nd, 2024 09:46AM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | |||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=7312 | 7312 | May 2nd, 2024 12:00AM | Open | Oncothyreon | Open | Company - Public | Biotech & Pharmaceuticals | Seattle, WA | 4.40 | 100% | 100% | 100% | 4.60 | 4.20 | 4.20 | -1.00 | 4.20 | 3.80 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 4.00 | 1.00 | 1.00 | Robert L. Kirkman | May 2nd, 2024 09:46AM | May 2nd, 2024 09:46AM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||||||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=12902 | 12902 | May 1st, 2024 12:00AM | Open | Seagen | Open | Company - Public | Biotech & Pharmaceuticals | Bothell, WA | 1998 | 4.20 | 82% | 64% | 87% | 4.40 | 4.40 | 4.00 | 4.30 | 3.90 | 3.90 | 11.00 | 6.00 | 29.00 | 42.00 | 78.00 | 166.00 | 192.00 | 50.00 | 6.627% | 3.614% | 17.47% | 25.301% | 46.988% | 15.00 | 0.00 | 428.00 | 0.54 | 0.21 | 0.25 | 0.66 | 0.18 | 0.11 | 0.01 | 0.01 | 0.02 | David Epstein | May 1st, 2024 09:25AM | May 1st, 2024 09:25AM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | ||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=7312 | 7312 | May 1st, 2024 12:00AM | Open | Oncothyreon | Open | Company - Public | Biotech & Pharmaceuticals | Seattle, WA | 4.40 | 100% | 100% | 100% | 4.60 | 4.20 | 4.20 | -1.00 | 4.20 | 3.80 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 4.00 | 1.00 | 1.00 | Robert L. Kirkman | May 1st, 2024 09:25AM | May 1st, 2024 09:25AM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||||||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=12902 | 12902 | Apr 30th, 2024 12:00AM | Open | Seagen | Open | Company - Public | Biotech & Pharmaceuticals | Bothell, WA | 1998 | 4.20 | 82% | 64% | 87% | 4.40 | 4.40 | 4.00 | 4.30 | 3.90 | 3.90 | 11.00 | 6.00 | 29.00 | 42.00 | 78.00 | 166.00 | 192.00 | 50.00 | 6.627% | 3.614% | 17.47% | 25.301% | 46.988% | 15.00 | 428.00 | 0.54 | 0.21 | 0.25 | 0.66 | 0.18 | 0.11 | 0.01 | 0.01 | 0.02 | David Epstein | Apr 30th, 2024 08:10AM | Apr 30th, 2024 08:10AM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology | |||||||
| nasdaq:sgen | https://www.glassdoor.com?employer_id=7312 | 7312 | Apr 30th, 2024 12:00AM | Open | Oncothyreon | Open | Company - Public | Biotech & Pharmaceuticals | Seattle, WA | 4.40 | 100% | 100% | 100% | 4.60 | 4.20 | 4.20 | -1.00 | 4.20 | 3.80 | 0.00 | 0.00 | 2.00 | 0.00 | 0.00 | 4.00 | 1.00 | 1.00 | Robert L. Kirkman | Apr 30th, 2024 08:10AM | Apr 30th, 2024 08:10AM | Seattle Genetics | Health Care | Pharmaceuticals & Biotechnology |